Further, PD-L1 expression on CML LSCs from CML mice with the combination treatment was significantly attenuated compared with imatinib alone (Supplementary Fig. 4g). This evidence concerns the gene CD274 and chronic myelogenous leukemia, BCR-ABL1 positive.